SCHEMBL8287899

SCHEMBL8287899

Cc1ccc2c(=O)cc(Nc3cccc(Cl)c3)n(-c3ccccc3)c2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
GAA P10253 3/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
HTT P42858 2/20 0.49
MAT2A P31153 4/20 0.47
MAPT P10636 3/20 0.42
NPSR1 Q6W5P4 2/20 0.41
ALPG P10696 1/20 0.41
ABCB1 P08183 1/20 0.41
ABCC1 P33527 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ADORA1 P30542 1/20 0.41
RIPK1 Q13546 1/20 0.41
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5872091 0.90 MAT2A (0.54) LMNASMN1; SMN2GAAALDH1A1HPGD
SCHEMBL8286340 0.89 GAA (0.50) LMNASMN1; SMN2GAAALDH1A1HPGD
SCHEMBL8287894 0.89 MAT2A (0.49) LMNASMN1; SMN2GAAALDH1A1HPGD
SCHEMBL8287872 0.87 MAT2A (0.47) LMNASMN1; SMN2ALDH1A1MAT2AMAPT
SCHEMBL8287369 0.86 MAT2A (0.52) LMNASMN1; SMN2ALDH1A1HTTMAT2A
SCHEMBL8286345 0.83 MAT2A (0.50) SMN1; SMN2ALDH1A1HPGDHTTMAT2A
SCHEMBL8287837 0.81 MAT2A (0.54) LMNASMN1; SMN2ALDH1A1HTTMAT2A
SCHEMBL8285127 0.80 PDE11A (0.44) LMNASMN1; SMN2GAAALDH1A1HPGD
SCHEMBL8287867 0.79 MAT2A (0.50) ALDH1A1HTTMAT2AMAPTNPSR1
SCHEMBL8287881 0.78 MAT2A (0.55) LMNAGAAALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed